Dr. Maureen Hanson has conducted groundbreaking molecular analysis of many facets of ME / CFS. She analyzes her data with sophistication and insight. It’s exciting to have such an accomplished top-notch scientist working on this disease.
Dr. Maureen Hanson is the Liberty Hyde Bailey Professor in the Department of Molecular Biology and Genetics at Cornell University. She previously was on the Biology faculty at the University of Virginia, Charlottesville. She holds a Ph.D. in Cell and Molecular Biology from Harvard University.
Drs. Øystein Fluge and Olav Mella have been courageous in pursuing their observations on the effects of rituximab on ME / CFS patients when that issue was not the planned focus of their investigation. They have continued to follow where the data lead them into cellular and molecular analyses. This kind of excellent, open-minded science is just what we need in our quest for an end to ME / CFS.
Dr. Fluge is the Senior Consultant supervising the ME / CFS research group at the Department of Oncology and Medical Physics at the University of Bergen, Haukeland University Hospital, Bergen, Norway. Dr. Mella is an adjunct professor working in the same group. They work together on the Norwegian Rituximab and cyclophosphamide trials with ME / CFS patients.
Donate your appreciated stock directly to OMF and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).